6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Ịdị ọcha ≥99.0% Favipiravir Intermediate COVID-19

Nkọwa dị mkpirikpi:

Aha: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide

Nọmba: 259793-88-9

ịdị ọcha: ≥99.0%

Otiti nke Favipiravir (CAS 259793-96-9) na ọgwụgwọ nke nje nje influenza na COVID-19

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Onye nrụpụta nwere ịdị ọcha dị elu yana ogo kwụsiri ike
Nbunye azụmaahịa Favipiravir na ihe ndị metụtara ya:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Njirimara kemịkalụ:

Aha Chemical	6-Bromo-3-Hydroxypyrazine-2-Carboxamide
Ụdị okwu	Favipiravir Intermediate;Favipiravir adịghị ọcha 4
Nọmba CAS	259793-88-9
Nọmba CAT	RF-PI296
Ọnọdụ Ahịa	Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms
Usoro ihe omimi	C5H4BrN3O2
Ibu molekụla	218.01
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Agba odo na ntụ ntụ ntụ ntụ
njirimara	IR, HPLC
Ọnwụ na ihicha	≤1.0%
Ihe fọdụrụ na mgbanye	≤0.20%
Otu adịghị ọcha	≤0.50%
Mgbakọta adịghị ọcha	≤1.0%
Ọla dị arọ	≤20ppm
Ihe mgbaze fọdụrụnụ	Zute nkọwapụta
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ọkara nke Favipiravir (CAS 259793-96-9)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.

Uru:

Ajụjụ:

Ngwa:

6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) bụ ihe etiti na-emekarị na njikọ nke 6-Bromo-3-Hydroxypyrazine-2-Carboxamide nke aha ya bụ Favipiravir (CAS 259793-96-9) ọgwụgwọ nke nje virus influenza.Ụzọ bara uru na usoro akụ na ụba na-aga Favipiravir.Favipiravir bụ ngwaahịa nyocha metụtara COVID19, na ọgwụgwọ ndị ọrịa nwere COVID-19 nke WHO kwadoro.Favipiravir, nke a makwaara dị ka T-705 ma ọ bụ Avigan, bụ ọgwụ mgbochi nje nke Toyama Chemical (Fujifilm Group) nke Japan mepụtara na-arụ ọrụ megide ọtụtụ nje RNA.A kwadoro Favipiravir maka ịzụ ahịa na Japan na March 2014 ma jiri ya mee ihe maka ọgwụgwọ antiviral nke influenza A na B. Na mgbakwunye na nje influenza, ọgwụ ahụ gosikwara ezigbo ọrụ antiviral na nje RNA dị iche iche, dị ka nje Ebola, nje virus ájá. Bunia nje, nje oria rabies, wdg. Na February 2020 a na-amụ Favipiravir na China maka nnwale nnwale nke ọrịa COVID-19 (Novel Coronavirus) na-egosi nsonaazụ dị mma.